. Author manuscript; available in PMC: 2023 Mar 1.

Published in final edited form as: Ophthalmol Glaucoma. 2021 Aug 18;5(2):128–136. doi: 10.1016/j.ogla.2021.08.003

Table 3:

Multivariable analysis of risk factors for primary open angle glaucoma

	95% Confidence Interval
Dependent variable: POAG	OR	Lower Bound	Upper Bound	p-Value
Age (years)	1.04	1.01	1.07	0.006
Gender (reference=female)	1.24	0.76	2.03	0.39
Race (reference=White)	4.75	2.76	8.16	<0.001
BMI (kg/m²)	1.01	0.96	1.06	0.69
Type 2 diabetes	2.31	1.24	4.29	0.008
Autoimmune disease	2.62	1.27	5.36	0.009
Any history of steroid use^a	0.65	0.33	1.27	0.21

Significant p-values are in bold.

Control subjects were the reference.

Any history of systemic steroid use for > 4 weeks in duration, inhaled steroid use for > 3 months in duration and topical steroid use for > 4 weeks in duration.

Abbreviations: BMI, body mass index; OR, odds ratio; POAG, primary open angle glaucoma.